Zoetis Inc. (ETR:ZOE)
Germany · Delayed Price · Currency is EUR | Market Cap | 47.36B |
| Revenue (ttm) | 8.01B |
| Net Income (ttm) | 2.26B |
| Shares Out | n/a |
| EPS (ttm) | 5.06 |
| PE Ratio | 20.96 |
| Forward PE | 18.96 |
| Dividend | 1.78 (1.66%) |
| Ex-Dividend Date | Oct 31, 2025 |
| Volume | 1 |
| Average Volume | 614 |
| Open | 105.00 |
| Previous Close | 107.78 |
| Day's Range | 105.00 - 105.00 |
| 52-Week Range | 97.50 - 170.22 |
| Beta | 0.97 |
| RSI | 42.69 |
| Earnings Date | Feb 13, 2026 |
About Zoetis
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph... [Read more]
Full Company ProfileFinancial Performance
In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.
Financial numbers in USD Financial StatementsNews
ZTS Stock: High Profitability Vs. Lagging Growth | 2-Minute Analysis
Zoetis Has Fallen Hard, But The Investment Case Is Still Not Obvious
Zoetis: Cheap Valuation And Attractive Product Launch Pipeline
Zoetis Inc at JPMorgan Healthcare Conference Transcript
Zoetis Inc at JPMorgan Healthcare Conference Transcript
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
Zoetis (ZTS) reached $125.32 at the closing of the latest trading day, reflecting a -1.45% change compared to its last close.
Zoetis Inc. (ZTS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zoetis Inc. (ZTS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
2026-01-12. The following slide deck was published by Zoetis Inc.
Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera
Stephanie Link, chief investment officer at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera
Stephanie Link, chief investment officer at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
2 Beaten-Down Stocks That Could Bounce Back in 2026
Viking Therapeutics has important catalysts on the horizon. Zoetis looks well-positioned to overcome recent challenges.
Why Zoetis Inc (ZTS) Is Set to Outperform the Market: Insights into Financial Growth and ...
Why Zoetis Inc (ZTS) Is Set to Outperform the Market: Insights into Financial Growth and Competitive Advantage
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 12, 2026. Chief Executive Officer Krist...
These stocks fell hard in 2025, but analysts see as much as 65% upside for them in 2026
Although the S&P 500 has returned 19.3% so far this year, dozens of stocks are showing significant declines for 2025.
ZTS Quantitative Stock Analysis - Warren Buffett
Below is Validea's guru fundamental report for ZOETIS INC (ZTS). Of the 22 guru strategies we follow, ZTS rates highest using our Patient Investor model based on the published strategy of Warren Buffe...
Trade Tracker: Stephanie Link buys mores Zoetis
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to explain why she's buying more Zoetis.
Trade Tracker: Stephanie Link buys mores Zoetis
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to explain why she's buying more Zoetis.
Zoetis (ZTS) Outperforms Broader Market: What You Need to Know
Zoetis (ZTS) closed at $123.78 in the latest trading session, marking a +1.26% move from the prior day.
Warren Buffett Detailed Fundamental Analysis - ZTS
Below is Validea's guru fundamental report for ZOETIS INC (ZTS). Of the 22 guru strategies we follow, ZTS rates highest using our Patient Investor model based on the published strategy of Warren Buffe...
Got $5,000? These 3 Growth Stocks Are Trading Near Their Lows.
Figma, Pinterest, and Zoetis are struggling this year due to a combination of high valuations and disappointing earnings. However, they possess some attractive long-term growth opportunities.
Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. Kristin Peck, Chief ...
These 2 Healthcare Stocks Just Declared Dividend Raises
One is a sector mainstay that has now raised its payout 17 years in a row. The other is a big player in the animal healthcare space.
4 Stocks That Declared Dividend Hikes Amid Ongoing Economic Uncertainty
CNP, VAC, PCG and ZTS raised dividends as tech volatility and economic uncertainty push income-focused investors toward steadier stocks.
Zoetis (ZTS) Launches $1.75 Billion Convertible Notes Offering
Zoetis (ZTS) Launches $1.75 Billion Convertible Notes Offering
Zoetis prices $1.75 billion convertible senior notes
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that it has priced its previously announced offering of $1.75 billion aggr...